Self-supervised AI model shows feasibility for detecting myofascial pain in small ultrasound studyCan a new AI tool spot shoulder pain from ultrasound videos in just a small group of patients?

Deep learning has transformed medical image and video analysis, but it usually requires large, well annotated datasets. In many clinical domains, especially when testing novel mechanistic hypotheses, such retrospective datasets are hard to obtain since acquiring adequate cohorts is time intensive, costly, and operationally difficult. This creates a critical translational gap: scientifically compelling early stage ideas may remain untested due to lack of sufficient sample size to support conventional deep learning pipelines. Developing data-efficient strategies for evaluating new hypotheses within small prospective cohorts is therefore essential to de-risk innovation before large-scale validation. Myofascial Pain Syndrome (MPS) exemplifies this challenge, as quantitative ultrasound imaging biomarkers for MPS remain underexplored. We investigated whether MPS in the upper trapezius can be detected from full B-mode ultrasound videos in a small prospective cohort (11 controls, 13 patients). Videos were automatically preprocessed and resampled using a sliding window strategy to expand training samples (404 clips). A self-supervised Video Diffusion Encoder (VDE) is developed to learn spatiotemporal representations without relying on extensive labeled data, and compared it with transfer-learning-based ResNet, VideoMAE, and SimCLR. Using subject-level stratified four-fold cross-validation, the VDE outperformed transfer learning baselines and achieved performance comparable to SimCLR, with subject-level AUC of 0.79 and accuracy of 0.86, and no significant differences between latent-only and combined trigger point analyses. These results demonstrate that self-supervised diffusion learning can support robust, data-efficient deep learning in small prospective studies, enabling early feasibility testing of innovative ultrasound biomarkers before large-scale clinical trials.